Trazodone 50 mg is a low dose of a prescription antidepressant that, in practice, is far more commonly dispensed for sleep than for depression. Approved by the FDA for major depressive disorder in adults, trazodone belongs to a class called serotonin antagonist and reuptake inhibitors (SARIs), and its pharmacology shifts depending on the dose. At 50 mg, the drug’s sedating properties dominate, which is why millions of prescriptions are written at this strength for insomnia even though the FDA never formally approved it for that purpose.
How Trazodone Works at Different Doses
Trazodone’s most distinctive feature is that what the drug does in your brain changes as the dose goes up. At lower doses, around 25 to 100 mg, it primarily blocks certain serotonin receptors and adrenaline-related receptors, which together produce sedation without the heavy “drugged” feeling of older sleep medications. A receptor-occupancy study found that at a 30 mg dose, trazodone mainly acts through its most potent properties: blocking serotonin 2A receptors and alpha-1 adrenergic receptors, along with partial activation of serotonin 1A receptors, achieving meaningful occupancy at those sites.1PubMed Central. Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations At the full antidepressant dose of around 300 mg per day, the drug recruits additional actions, including blockade of the serotonin transporter (the same target that SSRIs hit) plus activity at histamine and additional serotonin receptor subtypes.
This dose-dependent profile explains why a 50 mg tablet makes you sleepy but does not, on its own, treat depression in most people. The serotonin transporter blockade that drives the antidepressant effect only kicks in meaningfully at higher doses, typically 150 to 300 mg per day.2PubMed Central. Role of trazodone in treatment of major depressive disorder: an update So when your doctor prescribes 50 mg at bedtime, they are leveraging the sedation that comes from the lower-dose pharmacology while largely sidestepping the serotonin reuptake inhibition that defines its antidepressant action.
FDA-Approved Use for Depression
Trazodone’s only FDA-approved indication is major depressive disorder in adults. Clinical evidence shows its antidepressant effectiveness is comparable to other available antidepressants, with particular strengths in patients who also struggle with insomnia and agitation.2PubMed Central. Role of trazodone in treatment of major depressive disorder: an update The typical antidepressant dosing range is 150 to 300 mg per day, usually divided into multiple doses or given as a once-daily extended-release formulation. It is sometimes started at a lower dose and gradually increased over several weeks.
For depression, trazodone is also used at lower doses alongside another antidepressant. A patient taking an SSRI who still cannot sleep, for example, might be given trazodone 50 mg at bedtime as an adjunct. This combination targets two problems at once: the SSRI handles the core mood symptoms, while the low-dose trazodone addresses insomnia and can offset the sleep-disrupting effects that some SSRIs cause.
Off-Label Use for Insomnia
The vast majority of trazodone prescriptions at 50 mg are written for insomnia, not depression. This is one of the most widely prescribed off-label uses of any medication in the United States. The appeal is understandable: trazodone produces drowsiness without carrying the dependency risks associated with traditional sleeping pills. But the evidence base for this use is thinner than many people assume.
A systematic review and meta-analysis of trazodone’s effects on sleep architecture in people with insomnia found that, compared with control groups, trazodone increased total sleep time by about 40 minutes, cut the time it took to fall into sustained sleep by roughly 19 minutes, and reduced nighttime awakenings. It also boosted deep sleep (the stage associated with physical restoration) and reduced light, drowsy-stage sleep.3PubMed Central. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis An earlier study painted a slightly more nuanced picture, finding that trazodone halved the frequency of awakenings and increased deep sleep but did not change total sleep duration or the time needed to fall asleep, suggesting that it improved sleep quality more than quantity.4PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration
Despite its widespread use, a clinical appraisal published in 2023 noted a disconnect in the field: while most clinicians surveyed felt comfortable using trazodone for insomnia, an expert panel pointed out that the published evidence supporting it as a first-line sleep medication is limited. Some recent clinical guidelines do not recommend it as a go-to insomnia treatment, though that has done little to curb prescribing.5PubMed Central. Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal The gap between everyday practice and guideline recommendations is one of the quirks of trazodone’s story: it has become a default sleep aid partly because alternatives come with their own baggage, not because the evidence for trazodone is airtight.
How the Body Handles a 50 mg Dose
After you swallow a 50 mg tablet on an empty stomach, blood levels peak in about an hour. Taking it with food slows the peak to roughly two hours and reduces the intensity of that peak, though the total amount absorbed actually increases slightly.6Psychopharmacology Institute. What Is Trazodone 50 mg? Uses, Side Effects & Dosing – Section: Pharmacokinetics and Drug Interactions This is why many prescribers suggest taking trazodone with a light snack before bed: the slower absorption curve can reduce the dizziness some people feel as the drug hits its peak.
Trazodone’s half-life runs from about five to nine hours, meaning that by morning, most of the drug has cleared your system. For insomnia purposes, that is a reasonable fit: you get sedation through the night without a heavy hangover the next day. However, some people do report grogginess in the morning, especially at the start of treatment or if they take it too late in the evening.
The liver breaks trazodone down primarily through the CYP3A4 enzyme system, producing a metabolite called mCPP (meta-chlorophenylpiperazine).7Drug Metabolism and Disposition. Trazodone Is Metabolized to m-Chlorophenylpiperazine by CYP3A4 from Human Sources This metabolite is pharmacologically active and can cause some of trazodone’s side effects, particularly anxiety or restlessness in sensitive individuals. Its significance also matters for drug interactions, as discussed below.
Common Side Effects
The side effects most people notice at 50 mg are drowsiness (which is the intended effect when used for sleep), dry mouth, dizziness, and a mild lightheaded feeling upon standing. That lightheadedness has a specific name: orthostatic hypotension, a temporary drop in blood pressure when you go from lying down to upright. It happens because trazodone blocks alpha-1 adrenergic receptors, which play a role in maintaining blood pressure when you change position.
A study in older adults with high blood pressure found that trazodone users experienced a larger drop in blood pressure immediately after standing compared with non-users. The dip in the systolic reading was about 16 mmHg in trazodone users versus about 10 mmHg in non-users, and the diastolic drop was even more pronounced.8PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension For a young, healthy person taking 50 mg at bedtime, this usually just means standing up slowly if you get out of bed at night. For an older person already on blood-pressure medications, the risk is more meaningful and worth discussing with a prescriber.
Other common complaints include headache, nausea, blurred vision, and occasionally mild nasal congestion. Most of these tend to diminish after the first week or two as the body adjusts. Weight gain is uncommon at low doses, which distinguishes trazodone from several other medications used for sleep or depression.
Serious but Rare Adverse Effects
Two rare but important risks deserve mention. The first is priapism, a prolonged, painful erection unrelated to sexual arousal. This has been associated with trazodone since the drug’s early clinical use, and the proposed mechanism involves alpha-adrenergic blockade leading to impaired blood outflow from erectile tissue.9PubMed Central. Trazodone-Induced Ischemic Priapism Successfully Managed With Conservative Therapy: A Case Report Priapism is a medical emergency. Although the incidence is very low, anyone prescribed trazodone should know that an erection lasting more than four hours requires immediate medical attention.
The second is serotonin syndrome, a potentially dangerous condition that occurs when too much serotonin accumulates in the brain. Trazodone alone at 50 mg is unlikely to trigger this, but the risk climbs when trazodone is combined with other serotonergic drugs. A published case report described serotonin syndrome in a young man who was rapidly titrated on risperidone, trazodone, and sertraline simultaneously.10PubMed. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use The lesson is less about trazodone in isolation and more about caution when combining multiple medications that affect serotonin. Symptoms to watch for include agitation, rapid heartbeat, muscle twitching, and high fever.
Like all antidepressants, trazodone carries the FDA’s black-box warning about a possible increased risk of suicidal thoughts and behavior in young adults under 25, particularly in the early weeks of treatment. This warning applies across the antidepressant class and is not unique to trazodone.
Drug Interactions Worth Knowing
Because CYP3A4 handles most of trazodone’s metabolism, anything that strongly inhibits that enzyme can raise trazodone levels in the blood, sometimes substantially. Ketoconazole (an antifungal) and certain HIV protease inhibitors, particularly ritonavir and indinavir, are potent CYP3A4 inhibitors and have been shown to block the breakdown of trazodone in laboratory studies.11PubMed. In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors If you are taking a strong CYP3A4 inhibitor and your doctor adds trazodone, a lower starting dose is usually warranted.
Conversely, drugs that rev up CYP3A4 activity (like carbamazepine or rifampin) can speed trazodone’s clearance, potentially reducing its effectiveness. Grapefruit juice also inhibits CYP3A4 in the gut, though the clinical significance at a single 50 mg bedtime dose is likely modest for most people.
The combination of trazodone with alcohol deserves a straightforward mention: both are central nervous system depressants. Mixing them intensifies drowsiness and dizziness and amplifies the blood-pressure drop. Prescribers generally advise against drinking alcohol while taking trazodone, especially in the early adjustment period.
Trazodone and Fall Risk in Older Adults
Falls are the most clinically significant safety concern for older adults taking trazodone, and the research here is sobering. A large claims-based study found that older adults receiving insomnia medications, including trazodone, had over twice the odds of falls compared with controls, and trazodone carried some of the highest fall risk in the analysis.12PubMed Central. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines A separate matched-cohort study in nursing home residents concluded that new use of low-dose trazodone was no safer for fall-related injuries than new use of benzodiazepines, a class already considered high-risk for falls.13PubMed. Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study
The orthostatic hypotension discussed earlier is a big part of the problem. An older person who gets up in the dark to use the bathroom, already on blood-pressure medication, adds trazodone to the mix and stands up quickly — the combination can produce a blood-pressure drop steep enough to cause dizziness or fainting. The study in geriatric outpatients with hypertension found that trazodone use was independently associated with increased risk of syncope and falls even after accounting for age, physical performance, disability, and other medications.8PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension
There is a silver lining in one context: for older hospitalized adults with delirium, a nationwide cohort study found that trazodone users had a lower risk of rehospitalization and all-cause mortality compared with those given antipsychotic medications, with no significant difference in fall-related emergency visits.14The Lancet. Safety outcomes of trazodone versus antipsychotics for delirium after hospital admission in adults aged 65 years and older: a nationwide cohort study using a target trial emulation framework So the risk picture depends on what trazodone is being compared against: it may be riskier than taking nothing, but in certain clinical scenarios, it fares better than the alternatives.
How Trazodone Compares to Other Sleep Medications on Dependence
One reason trazodone became so popular for insomnia is that it does not work like benzodiazepines or Z-drugs (like zolpidem). It does not act on GABA receptors, which means it avoids the tolerance, rebound insomnia, and physiological dependence profile that makes those medications worrisome for long-term use. Pharmacovigilance data show that drug-abuse and drug-dependence reports with trazodone are markedly lower than with benzodiazepines.15Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. P.052 Trazodone for treating insomnia: abuse and safety risks
A retrospective study comparing trazodone and mirtazapine (another antidepressant used off-label for sleep) found that both maintained their effectiveness over time at low doses without apparent tolerance developing.16PubMed. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study This sustained efficacy is a meaningful advantage. Many people taking Z-drugs notice the effect wearing off after weeks to months, leading them to request dose increases. Trazodone’s mechanism is different enough that this escalation cycle is far less common.
That said, trazodone is not entirely free from discontinuation effects. Some people who stop abruptly after prolonged use report rebound insomnia, irritability, or anxiety. The earlier sleep study noted a rebound increase in REM sleep above baseline after trazodone withdrawal, along with a drop in deep sleep.4PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration Tapering gradually rather than stopping cold is the standard advice.
Trazodone Compared to Zolpidem for Fracture Risk
Given that both trazodone and zolpidem are widely prescribed for sleep, their head-to-head safety profile matters. A study of over 31,000 patients on maintenance hemodialysis — a population already prone to falls — found that zolpidem initiation carried a higher risk of hospitalized fall-related fractures compared with trazodone initiation, with a weighted hazard ratio of about 1.7.17PubMed Central. Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis This is a specific, high-risk population, so the result cannot be directly generalized to everyone. But for patients with kidney disease or other conditions that increase fall vulnerability, trazodone appears to carry a somewhat lower fracture risk than zolpidem.
Pregnancy, Breastfeeding, and Trazodone
Data on trazodone during pregnancy are sparse, and no large-scale studies have established its safety profile for pregnant women. What exists are small studies and case reports. One case report measured trazodone and its metabolite mCPP in cord blood and found concentrations comparable to maternal levels, meaning the drug does cross the placenta. The infant in that case developed normally through six months of follow-up with no drug-related adverse effects, but the authors stressed that the effects on the fetus remain unclear and more research is needed.18PubMed Central. Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum
For breastfeeding, the news is somewhat more reassuring. A study of six lactating women given a single 50 mg dose found that the amount of trazodone excreted in breast milk was very small — the milk-to-plasma ratio was only about 0.14, and a breastfed infant would be exposed to less than 0.005 mg per kilogram of body weight, a tiny fraction of the mother’s dose.19PubMed Central. Excretion of trazodone in breast milk That is one of the lowest milk-to-plasma ratios among antidepressants. Still, individual discussions with a prescriber are warranted, since the data come from a very small sample and no long-term infant outcomes have been studied systematically.
Trazodone in Veterinary Medicine
If your veterinarian has ever prescribed trazodone for your dog or cat, you are not alone. The same pharmacological properties that make it useful for human insomnia and anxiety also make it a popular choice for situational behavioral problems in companion animals, such as pre-visit anxiety, noise phobias, or post-surgical confinement stress.20Russian veterinary journal. Trazodone succinate — new opportunities for pharmacological correction of situational behavioral abnormalities in dogs and cats Veterinary doses differ from human doses and are weight-adjusted, so sharing your own prescription with a pet is never safe. But the crossover use underscores how trazodone’s sedative profile at low doses has found applications well beyond its original psychiatric indication.